甘李药业：公司严格按照法律法规履行信息披露义务

Group 1 - The company, Ganli Pharmaceutical (603087), stated that it strictly adheres to legal and regulatory obligations regarding information disclosure [1] - The company will promptly announce any relevant R&D or business progress that meets the disclosure standards [1] - Investors are advised to pay attention to announcements published by the company on the Shanghai Stock Exchange and other designated media [1]